CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Jonathan Albrett, Director of Clinical Training, Taranaki District Health Board

Jonathan Albrett, Director of Clinical Training

Workforce Pipeline Securing New Zealand's Medical Future

Jonathan Albrett

Jonathan Albrett

Jonathan Albrett brings extensive expertise to his role as Director of Clinical Training at Te Whatu Ora Taranaki. A 2002 graduate of the University of Auckland Medical School, he holds fellowships from the Australian and New Zealand College of Anaesthesia, as well as the College of Intensive Care Medicine of Australia and New Zealand.


Dr. Albrett specializes in anesthesia and intensive care medicine. He is passionate about medical education, guiding both medical students and prevocational doctors. His interests include medical transport, simulation, deteriorating patient care, and sleep medicine.


Dr. Albrett's commitment to clinical training fosters the development of the next generation of skilled medical practitioners in New Zealand.


Through this article, Albrett shares his insights on the challenges and opportunities facing clinical training in New Zealand. He discusses the evolving healthcare landscape, strategies for developing a skilled medical workforce and the role of initiatives and technological advancements in shaping the future of medical education.


As a leader involved in clinical training, what are the most significant challenges you see in the sector today?


The healthcare sector faces significant challenges. Increasing graduate numbers coincide with complex cases and busy work environments, requiring young doctors to navigate chronic diseases, treatment options, and aging populations.


Newly qualified doctors often have strong understandings of inequities and bias, contrasting with senior practitioners. This creates a dynamic learning environment where even experts can benefit from trainees' insights, requiring adjustment on all sides.


There's a disconnect between idealistic university expectations and practical workplace realities, causing a jarring transition for junior doctors.


The pandemic's impact on learning cannot be ignored, as doctors trained during this period may have less hands-on experience, necessitating a focus on rebuilding teamwork skills.


Younger staff may not fully grasp the impact of changing governance structures, which can create insecurity among senior leaders with consequences for junior professionals.


Could you talk about recent initiatives or technological advancements aiding the challenges faced in clinical training?


In New Zealand, we've seen positive developments with a nationwide network of educators. Most hospitals now have dedicated Directors of Clinical Training, including myself in the Taranaki region. This network fosters ongoing consultation, sharing of strategies, and collaborative problem-solving.


Looking ahead, I anticipate a strong emphasis on workforce pipeline development over the next two years, through specialty and national initiatives. The aim is to develop and integrate more domestic graduates into the healthcare system, ensuring high-quality positions with excellent training and supervision.


By providing certainty and support within New Zealand, we’ll encourage more to stay and potentially attract those from abroad.


The establishment of national specialty networks is another promising development. These will focus on expanding training workforces, leading to streamlined, accessible pathways for trainees and facilitating timely graduation.


While AI has not yet seen mainstream use in junior doctor training, I believe it will become a significant component within the next couple of years.


Could you elaborate on the potential long-term benefits you see for the medical field, maybe a few years down the line?


The establishment of a workforce pipeline over the next two years promises significant long-term benefits. Graduating doctors should have a clearer vision of their career trajectories, encouraging more to stay in New Zealand and potentially attracting talent from abroad.


One area with immense potential is the training of general practitioners (GPs). My involvement in a pilot program demonstrated the power of early community exposure, as doctors placed directly into general practice settings are more likely to remain in that field, addressing the looming GP shortage.


I foresee a shift towards community-based medical training, moving beyond the traditional hospital-centric model. This could factor into the development of a third medical school, with more doctors opting for general practice from the start. As community work becomes more appealing, hospitals may need to offer more attractive terms to compete for graduates, empowering young doctors with greater choice and flexibility - a positive development for the sector.


Would you be willing to share some stories about those who've had the most influence on your development?


Throughout my career, I've had the privilege of observing truly exceptional leaders in action. Early on, as a new fellow representative on a New Zealand committee, I witnessed senior members like Ross Freeburn navigate negotiations, quality control, and interactions with other groups with remarkable skill, presenting compelling arguments and achieving their goals with integrity.


My experience on the Medical Council's education committee offered further opportunities to learn from extraordinary leaders. George Knaysi, Curtis Walker, and King Clark exemplified effective leadership, empowering team members, validating their contributions, and fostering their professional growth, while prioritizing the development of others over seeking personal recognition. These experiences had a profound impact on shaping my own leadership style, emphasizing collaboration and bringing out the best in those around me.


What advice would you offer to those looking to excel in clinical training?


Clinical training requires patience above all. Understand that the essence of medicine is in its practice, where hands-on experience is invaluable over time. My advice is to embrace patience and recognize that excellence in medicine is a marathon, not a sprint, though the rewards are fulfilling.


Medical training involves an intense focus on your own progress, exams, and qualifications, requiring self-centeredness. But the art of medicine transforms once you've crossed that threshold, with a shift from individual achievements to collective success. You'll need to learn how to be an effective team player, leverage those around you, and contribute to a collaborative environment.


The future of medicine isn't about solo brilliance, but how well you work within a team and contribute to collective expertise. It's a balance of pushing yourself to learn and grow, then shifting to foster success in a team setting.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/jonathan-albrett-nwid-2487.html